In recent years, the very high worldwide prevalence of chronic kidney disease (CKD) has led some authors to talk of an “epidemic.” The progression of CKD varies considerably among individuals despite similar aetiologies, optimal blood pressure, and glycaemic control. Over the last decade, through genome-wide association studies (GWAS), more than 50 genetic loci have been identified in association with CKD. Understanding the genetic basis of CKD could provide a better knowledge of the biology of the involved pathways, thus potentially leading to novel tools for the diagnosis, prevention, and therapy of CKD. In this review, we will analyse the role of GWAS in the study of CKD.

Keywords:
Chronic kidney disease, Rare renal diseases, Genome-wide analysis studies, Genetic markers, Kidney traits
1.
Zoccali C, Kramer A, Jager KJ: Epidemiology of CKD in Europe: an uncertain scenario. Nephrol Dial Transplant 2010;25:1731-1733.
2.
Wali RK, Henrich WL: Chronic kidney disease: a risk factor for cardiovascular disease. Cardiol Clin 2005;23:343-362.
3.
O'Seaghdha CM, Fox CS: Genetics of chronic kidney disease. Nephron Clin Pract 2011;118:c55-c63.
4.
Placha G, Canani LH, Warram JH, Krolewski AS: Evidence for different susceptibility genes for proteinuria and ESRD in type 2 diabetes. Adv Chronic Kidney Dis 2005;12:155-169.
5.
Pe'er I, Yelensky R, Altshuler D, Daly MJ: Estimation of the multiple testing burden for genomewide association studies of nearly all common variants. Genet Epidemiol 2008;32:381-385.
6.
McCarthy MI, Hirschhorn JN: Genome-wide association studies: potential next steps on a genetic journey. Hum Mol Genet 2008;17: R156-R165.
7.
O'Seaghdha C, Fox C: Genome-wide association studies of chronic kidney disease: what have we learned? Nat Rev Nephrol 2011;8:89-99.
8.
Köttgen A, Glazer N, Dehghan A, et al: Multiple loci associated with indices of renal function and chronic kidney disease. Nat Genet 2009;41:712-717.
9.
Chambers J, Zhang W, Lord G, et al: Genetic loci influencing kidney function and chronic kidney disease. Nat Genet 2010;42:373-375.
10.
Price PM, Hirschhorn K, Safirstein RL: Chronic kidney disease and GWAS: “the proper study of mankind is man.” Cell Metab 2010;11:451-452.
11.
Köttgen A, Pattaro C, Böger C, et al: New loci associated with kidney function and chronic kidney disease. Nat Genet 2010;42:376-384.
12.
McCarthy MI, Abecasis GR, Cardon LR, Goldstein DB, et al: Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat Rev Genet 2008;9:356-369.
13.
Pattaro C, Köttgen A, Teumer A, et al: Genome-wide association and functional follow-up reveals new loci for kidney function. PLoS Genet 2012;8:e1002584.
14.
Pattaro C, Teumer A, Gorski M, et al: Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function. Nat Commun 2016;7:10023.
15.
Parsa A, Kanetsky PA, Xiao R, et al: Genome-wide association of CKD progression: the chronic renal insufficiency cohort study. J Am Soc Nephrol 2017;28:923-934.
16.
Böger CA, Gorski M, Li M, Hoffmann MM, et al: Association of eGFR-related loci identified by GWAS with incident CKD and ESRD. PLoS Genet 2011;7:e1002292.
17.
Pani A, Bragg-Gresham J, Masala M: Prevalence of CKD and its relationship to eGFR-related genetic loci and clinical risk factors in the SardiNIA study cohort. J Am Soc Nephrol 2014;25:1533-1544.
18.
Susztak K: Understanding the epigenetic syntax for the genetic alphabet in the kidney. J Am Soc Nephrol 2014;25:10-17.
19.
Drawz P, Sedor J: The genetics of common kidney disease: a pathway toward clinical relevance. Nat Rev Nephrol 2011;7:458-468.
20.
Scolari F, Izzi C, Ghiggeri G: Uromodulin: from monogenic to multifactorial diseases. Nephrol Dial Transplant 2015;30:1250-1256.
21.
Gudbjartsson D, Holm H, Indridason O, et al: Association of variants at UMOD with chronic kidney disease and kidney stones - role of age and comorbid diseases. PLoS Genet 2010;6:e1001039.
22.
Khalili H, Sull A, Sarin S, et al: Developmental origins for kidney disease due to Shroom3 deficiency. J Am Soc Nephrol 2016;27:2965-2973.
23.
Stanescu HC, Arcos-Burgos M, Medlar A, Bockenhauer D, et al: Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy. N Engl J Med 2011;364:616-626.
24.
Gharavi AG, Kiryluk K, Choi M, Li Y, et al: Genome-wide association study identifies susceptibility loci for IgA nephropathy. Nat Genet 2011;43:321-327.
25.
Yu XQ, Li M, Zhang H, Low HQ, et al: A genome-wide association study in Han Chinese identifies multiple susceptibility loci for IgA nephropathy. Nat Genet 2011;44:178-182.
26.
Feehally J, Farrall M, Boland A, Gale DP, et al: HLA has strongest association with IgA nephropathy in genome-wide analysis. J Am Soc Nephrol 2010;21:1791-1797.
27.
Kiryluk K, Li Y, Scolari F, Sanna-Cherchi S, et al: Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens. Nat Genet 2014;46:1187-1196.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.